Jin-xue Zhou

Targeting CXCL5 in Pancreatic Cancer Cells Inhibits Cancer Xenograft Growth by Reducing Proliferation and Inhibiting EMT Progression

Zhengzheng Wang, Qingjun Li, Xiao-ting Li, 2022, Digestive Diseases and Sciences.

Tumor-infiltrating CD4+ T cells in patients with gastric cancer

P. Yuan, Q. Gao, Z. Run, 2017, Cancer Cell International.

HBXIP drives metabolic reprogramming in hepatocellular carcinoma cells via METTL3‐mediated m6A modification of HIF‐1α

Zhengzheng Wang, R. Zhu, Qingjun Li, 2020, Journal of cellular physiology.

Challenges Facing Percutaneous Ablation in the Treatment of Hepatocellular Carcinoma: Extension of Ablation Criteria

Yanzhao Zhou, J. Ouyang, Zhengzheng Wang, 2021, Journal of hepatocellular carcinoma.

Genetic Analysis of Pediatric Pancreatoblastoma: A Case Report.

Xiaoting Li, Zhengzheng Wang, Qingjun Li, 2021, Pancreas.

Using the aMAP Risk Score to Predict Late Recurrence Following Radiofrequency Ablation for Hepatocellular Carcinoma in Chinese Population: A Multicenter Study

Xi Wei, Xinyuan Zhang, Qiang Li, 2021, Journal of hepatocellular carcinoma.

Gallbladder cancer: current and future treatment options

Zemin Ji, Yanzhao Zhou, J. Ouyang, 2023, Frontiers in Pharmacology.

A novel internal cold circulation radiofrequency-assisted device for liver transection

Yanzhao Zhou, J. Ouyang, Zhengzheng Wang, 2021, International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group.

Textbook outcomes in liver surgery for gallbladder cancer patients treated with curative-intent resection: a multicenter observational study

W. Lau, Yi Zhu, Fan Huang, 2023, International journal of surgery.

Adjuvant Lenvatinib Plus PD-1 Antibody for Hepatocellular Carcinoma with High Recurrence Risks After Hepatectomy: A Retrospective Landmark Analysis

Yi Yang, Yanzhao Zhou, J. Ouyang, 2023, Journal of hepatocellular carcinoma.

Predictive Factors of Treatment Outcomes After Percutaneous Radiofrequency Ablation of Hepatocellular Carcinoma in the Hepatocaval Confluence: A Propensity Score Matching Analysis.

Yi Yang, Zemin Ji, Yanzhao Zhou, 2023, Academic radiology.

The MAPS-CRAFITY score: a novel efficacy predictive tool for unresectable hepatocellular carcinoma treated with targeted therapy plus immunotherapy

Yezhou Yang, X. Zhao, Wen Zhang, 2023, Hepatology International.